KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Vertex Pharmaceuticals (VRTX) Return on Invested Capital (2016 - 2025)

Historic Return on Invested Capital for Vertex Pharmaceuticals (VRTX) over the last 14 years, with Q4 2025 value amounting to 0.2%.

  • Vertex Pharmaceuticals' Return on Invested Capital rose 1700.0% to 0.2% in Q4 2025 from the same period last year, while for Dec 2025 it was 0.2%, marking a year-over-year increase of 1700.0%. This contributed to the annual value of 0.2% for FY2025, which is 1700.0% up from last year.
  • Per Vertex Pharmaceuticals' latest filing, its Return on Invested Capital stood at 0.2% for Q4 2025, which was up 1700.0% from 0.19% recorded in Q3 2025.
  • Vertex Pharmaceuticals' Return on Invested Capital's 5-year high stood at 0.29% during Q2 2022, with a 5-year trough of 0.15% in Q1 2025.
  • Its 5-year average for Return on Invested Capital is 0.18%, with a median of 0.2% in 2021.
  • The largest annual percentage gain for Vertex Pharmaceuticals' Return on Invested Capital in the last 5 years was 1700bps (2025), contrasted with its biggest fall of -3400bps (2025).
  • Over the past 5 years, Vertex Pharmaceuticals' Return on Invested Capital (Quarter) stood at 0.24% in 2021, then grew by 4bps to 0.25% in 2022, then dropped by -26bps to 0.18% in 2023, then tumbled by -83bps to 0.03% in 2024, then soared by 535bps to 0.2% in 2025.
  • Its last three reported values are 0.2% in Q4 2025, 0.19% for Q3 2025, and 0.19% during Q2 2025.